Boris Pasche
Chief Executive Officer bei Therabionic LLC
Vermögen: 81 347 $ am 31.03.2024
Profil
Boris C.
Pasche is the founder of Therabionic LLC,Therabionic GmbH.
He is currently the Chairman of the Cancer Research Department at Wake Forest University, Director at The Foundation For Research On Information Technologies In Soc, Member of the American Society for Clinical Investigation, and Member of the American Clinical & Climatological Association.
Previously, he was the Director of the Hematology & Oncology Division at the University of Alabama Medical Center, Director of the Hematology & Oncology Division at The University of Alabama at Birmingham, Director at Wake Forest Baptist Medical Center, Deputy Director at Uab Comprehensive Cancer Center, and Associate Director at The Journal of Precision Medicine.
He also served as an Independent Director at Rafael Holdings, Inc. from 2018 to 2023.
Dr. Pasche holds a doctorate degree from Karolinska Institutet and the University of Lausanne.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
05.01.2023 | 47 295 ( 0,20% ) | 81 347 $ | 31.03.2024 |
Aktive Positionen von Boris Pasche
Unternehmen | Position | Beginn |
---|---|---|
Therabionic LLC | Chief Executive Officer | - |
Therabionic GmbH | Chief Executive Officer | - |
Wake Forest University | Corporate Officer/Principal | - |
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology American Society for Clinical Investigation engages as a medical honor society. It focuses on physician-scientists in research, clinical care, and medical education. The company was founded by Samuel J. Meltzer in 1908 and is headquartered in Ann Arbor, MI. | Corporate Officer/Principal | - |
The Foundation For Research On Information Technologies In Soc | Director/Board Member | - |
American Clinical & Climatological Association | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Boris Pasche
Unternehmen | Position | Ende |
---|---|---|
RAFAEL HOLDINGS, INC. | Director/Board Member | 08.08.2023 |
The Journal of Precision Medicine | Corporate Officer/Principal | 01.01.2016 |
The University of Alabama at Birmingham | Corporate Officer/Principal | 01.01.2014 |
░░░ ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Boris Pasche
Karolinska Institutet | Doctorate Degree |
University of Lausanne | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
RAFAEL HOLDINGS, INC. | Finance |
Private Unternehmen | 9 |
---|---|
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology American Society for Clinical Investigation engages as a medical honor society. It focuses on physician-scientists in research, clinical care, and medical education. The company was founded by Samuel J. Meltzer in 1908 and is headquartered in Ann Arbor, MI. | Health Technology |
University of Alabama Medical Center | |
Wake Forest Baptist Medical Center
Wake Forest Baptist Medical Center Medical/Nursing ServicesHealth Services Wake Forest Baptist Medical Center operates as a medical center. It provides volunteer services such as application process, adult volunteers, college student volunteer program and summer volunteer program. The company was founded in 1834 and is headquartered in Winston-Salem, NC. | Health Services |
Therabionic LLC | |
Therabionic GmbH | |
Uab Comprehensive Cancer Center | |
The Journal of Precision Medicine | |
American Clinical & Climatological Association | |
The Foundation For Research On Information Technologies In Soc |